International Journal of Dermatology· 2026Q1
Low‐Dose Tumescent Triamcinolone‐Clindamycin Mixture for Hidradenitis Suppurativa: A Case Series
- 0citations
- Q1SCImago
- 2026year
Short summary
A novel tumescent mixture of low-dose triamcinolone and clindamycin injected directly into hidradenitis suppurativa (HS) lesions showed promising results in a case series.
AI-generated from the title and abstract; the full text is not read.
Key points
- A tumescent mixture of low-dose triamcinolone and clindamycin was injected directly into HS lesions.
- This localized injection method is presented as a novel treatment approach for HS.
- The case series suggests potential efficacy and good tolerability for this treatment.
AI-generated from the title and abstract; the full text is not read.
Abstract
The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
The authors' abstract, as published at the source. International Journal of Dermatology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Dermatology
DermatologyMedicine